About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Co-occurring AF and HF: Treatment Selection
By
Northwestern Medicine: 8th Annual Cardiovascular Update
FEATURING
Clyde Yancy
,
Jonathan Piccini
By
Northwestern Medicine: 8th Annual Cardiovascular Update
FEATURING
Clyde Yancy
,
Jonathan Piccini
828 views
August 6, 2019
Clyde W. Yancy, MD, MSc and Jonathan P. Piccini, Sr., MD, MHSc discuss “Co-occurring AF
...
read more ↘
and HF: Treatment Selection” at the Northwestern Medicine 8th Annual Chicago Cardiovascular Update CME event.
↖ read less
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
12:30
Houston Methodist Hospital
Amyloidosis Types and Pathophysiology
Feat.
B. Trachtenberg
51:47
Boston Scientific
Biophysics of Ablation – Fundamentals and Myths
Feat.
R. Tung,
D. Haines
27:14
MUSC Cardiology
Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…
Feat.
R. Mentz
31:46
ACC 2024 Insights
ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …
Feat.
M. Costanzo
13:07
Michelle Kittleson
2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …
09:52
AHA 2022 Conference Coverage
AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…
Feat.
R. Mentz
13:54
Stanford Medicine
How I Manage Patients with Frequent PVCs
Feat.
R. John
18:36
The Texas Heart Institute
Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?
Feat.
M. Razavi
35:16
Scripps Health
HFpEF or Amyloidosis? The Right Therapies for Right Patients
Feat.
M. Kittleson
14:19
UChicago Medicine
S-QUAD Therapy and Beyond: HFpEF in 2024
Feat.
M. Belkin
17:29
UCLA Health
Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics
Feat.
D. Vucicevic
06:23
CVRx | Barostim
ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…
Feat.
W. Abraham,
F. Arribas,
M. Zile
11:49
CVRx | Barostim
ESC 2023: Unmet needs and opportunities with device therapies of HFr…
Feat.
W. Abraham
06:16
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT
Feat.
D. Yaranov
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
40:17
American College of Cardiology
Heart Failure with Preserved Ejection Fraction: Current Perspectives…
Feat.
S. Shah
34:18
Scripps Health
Cancer Survivorship: How To Monitor for Cardiac Disease Following Tr…
Feat.
A. Kuo
84:17
Jefferson Health
2022 Heart Failure Guidelines Review
Feat.
D. Haas
